Company Overview and News

Add 4514
to your dashboard

Headline News

Pieris Pharmaceuticals' (PIRS) CEO Stephen Yoder on Q3 2017 Results - Earnings Call Transcript

2017-11-10 seekingalpha
Greetings, and welcome to the Pieris Pharmaceuticals Third Quarter 2017 Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow a formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Allan Reine. Please go ahead, sir. (41-4)